Assessment of the Relationship Between Vitamin B12 Vitamin Deficiency and Severe Depression

Yıl 2020, , 71 - 76, 01.04.2020

Merve Hafızoğlu

https://doi.org/10.32708/uutfd.700927

Cited By: 1

Öz

Vitamin B12 deficiency is an important public health problem. There are many publications in the literature showing the relationship between vitamin B12 deficiency and severe depression. Beck depression scale (BDI) is a depression scale based on clinical observation and data consisting of 21 symptom categories. In this study, we aimed to investigate the relationship between vitamin B12 deficiency and depression by using BDI. This study was conducted with 114 patients who applied to the department of internal medicine, Afyon Health Science University Hospital with any complaints. Demographic features of patients such as age, gender, educational status, comorbid diseases and vitamin B12 levels, homocysteine levels, folic acid and ferritin levels were examined. Depression status of patients were determined to BDI. The patients were divided into 2 groups, vitamin B12 below and above 196 pg/mL and the data of the groups were compared. The mean BDI score of the group with low vitamin B12 level was 14.6±7.9, and the mean BDI score of the group with high vitamin B12 level was 11.6±7.2. When the two groups were compared according to the BDI score, the difference was statistically significant (p=0.041). As a result, the effect of vitamin B12 on cognitive functions and depressive symptoms is obvious. In our study, in accordance with the literature, BDI score was found to be high in the group with low vitamin B12. However, it may not be right to just connect it to the vitamin B12 level. Further, prospective studies are needed to determine the benefit of vitamin B12 in the treatment of depression.

Anahtar Kelimeler

Vitamin B12, Beck Depression Scale, Homocysteine, Folic acid, Ferritin

B12 Vitamini Eksikliğinin Depresyon İle İlişkisinin Değerlendirilmesi

Öz

B12 vitamin eksikliği önemli bir toplum sağlığı sorunudur. Literatürde B12 vitamini eksikliğinin ağır depresyon ile ilişkisini gösteren birçok yayın mevcuttur. Beck Depresyon Ölçeği (BDÖ), 21 belirti kategorisinden oluşan klinik gözlem ve verilere dayanılarak oluşturulan bir depresyon ölçeğidir. Biz de bu çalışmada BDÖ’yü kullanarak B12 vitamini eksikliğinin depresyon ile ilişkisini araştırmayı amaçladık. Bu çalışma herhangi bir şikayetle Afyonkarahisar Sağlık Bilimleri Üniversitesi Hastanesi İç Hastalıkları Anabilim Dalı Polikliniğine başvuran 114 hasta ile yapıldı. Hastaların yaş, cinsiyet, eğitim durumu, komorbid hastalıkları gibi demografik özellikleri ve B12 vitamin düzeyleri, homosistein düzeyleri, folik asit ve ferritin düzeyleri incelendi. BDÖ’ye göre hastaların depresyon durumları belirlendi. Hastalar B12 vitamini 196 pg/ml altında ve üstünde olmak üzere 2 gruba ayrılarak grupların verileri karşılaştırıldı. B12 vitamin düzeyi düşük olan grubun ortalama BDÖ skoru 14,6±7,9, B12 vitamin düzeyi yüksek olan grubun ortalama BDÖ skoru 11,6±7,2 idi. Her iki grup BDÖ skoruna göre karşılaştırıldığında aradaki fark istatistiki olarak anlamlı saptandı (p=0,041). Sonuç olarak B12 vitamininin kognitif fonksiyonlar ve depresif semptomlar üzerine etkisi aşikardır. Bizim çalışmamızda da literatür ile uyumlu olarak B12 vitamini düşük olan grupta BDÖ skoru anlamlı olarak yüksek saptandı. Ancak bunu sadece B12 vitamin düzeyine bağlamak doğru olmayabilir. B12 vitamininin depresyon tedavisinde faydasını belirlemek üzere daha geniş, prospektif çalışmalara ihtiyaç duyulmaktadır.

Anahtar Kelimeler

B12 vitamini, beck depresyon ölçeği, homosistein, folik asit, ferritin

Kaynakça

• 1. Kalem P, Benli AR, Koroglu M, Benli NC, Koyuncu M, Cesur O, et al. The effect of ferritin, vitamin B12 and folic acid on pregnancy outcomes. Int J Clin Exp Med. 2016;9(11):22413-7.
• 2. Garcia-Casal M, Osorio C, Landaeta M, Leets I, Matus P, Fazzino F, et al. High prevalence of folic acid and vitamin B12 deficiencies in infants, children, adolescents and pregnant women in Venezuela. European Journal of Clinical Nutrition. 2005;59(9):1064-70.
• 3. Koç A, Koçyiğit A, Ulukanlıgil M, Demir N. Şanlıurfa yöresinde 9-12 yaş grubu çocuklarda B12 vitamini ve folik asit eksikliği sıklığı ile bağırsak solucanlarıyla ilişkisi. Çocuk Sağlığı ve Hastalıkları Dergisi. 2005;48:308-15.
• 4. Belghith A, Mahjoub S, Ben RN. Causes of vitamin B12 deficiency. La Tunisie medicale. 2015;93(11):678-82.
• 5. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood. 2005;105(3):978-85.
• 6. Dharmarajan TS, Norkus E, Ehrenpreis E, Herbert V, Swain R, Harris M. Vitamin B 12 deficiency in the elderly population based research. Round Table Series-Royal Society of Medicine. 1999(66):27-33.
• 7. Hutto BR. Folate and cobalamin in psychiatric illness. Compr Psychiatry 1997;38:305–14.
• 8. Kim H, Kim G, Jang W, et al. Association between intake of B vitamins and cognitive function in elderly Koreans with cognitive impairment. Nutr J 2014;13:118.
• 9. Yi X, Feng H, Peng S, et al. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson’s disease: a meta-analysis. Neurosci Lett 2017;636:190–5.
• 10. Joosten E, van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP,et al. Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services. Am J Clin Nutr 2003;77:211–20.
• 11. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449–55.
• 12. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202.
• 13. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002;346:476–83.
• 14. Stahl SM: Stahl`s essential psychopharmacology. Neuroscientific basis and practical applications. 3rd edition. Cambridge, UK: Cambridge University Press; 2008.
• 15. Bell IR, Edman JS, Morrow FD, Marby DW, Mirages S, Rerrone G: B complex vitamin patterns in geriatric and young adult inpatients with majordepression. J Am Geriatr Soc 1991, 39:252–257.
• 16. Mischoulon D, Burger JK, Spillmann MK, Worthington JJ, Fava M, Alpert JE: Anemia and macrosytosis in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression. J Psychosom Res 2000, 49:183–187.
• 17. Hvas AM, Juul S, Lauritzen L, et al: No effect of vitamin B12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affect Disord 2004, 81:269–273.
• 18. Ceylan R. Entegre Eğitime Katılan ve Katılmayan Engelli Çocukların Annelerinin depresyon ve Umutsuzluk Düzeylerinin İncelenmesi (Uzmanlık Tezi). Ankara: Ankara Üniversitesi; 2004.
• 19. Pawlak R, Lester S, Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. European journal of clinical nutrition. 2014;68(5):541-8.
• 20. Ng T-P, Feng L, Niti M, Kua E-H, Yap K-B: Folate, vitamin B12,homocysteine, and depressive symptoms in a population sample of older Chinese adults. JAGS 2009, 57:871–876.
• 21. Tiemeier H, van Tuijl H, Hofman A, Meijer J, Kiliaan A, Breteler M: VitaminB12, folate and homocysteine in depression: the Rotterdam study. Am J Psychiatry 2002, 159:2099–2101.
• 22. Seppälä J, Koponen H, Kautiainen H, Eriksson J, Kampman O, Leiviska J, et al. Hannu et al. Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population based study. BMC Psychiatry 2013, 13:145.
• 23. Xuan Zhou , Qing Wang, Peilin An, Yue Du, Jiangang Zhao, Aili Song et al. Relationship between folate, vitamin B12, homocysteine, transaminase and mild cognitive impairment in China: a case-control study.International Journal of food sciences and nutrition. doi: 10.1080/09637486.2019.1648387 .
• 24. Baroni L, Bonetto C, Rizzo G, Bertola C, Caberlotto L, Bazzerla G. Association Between Cognitive Impairment and Vitamin B12, Folate, and Homocysteine Status in Elderly Adults: A Retrospective Study. J Alzheimers Dis. 2019;70(2):443-453. doi: 10.3233/JAD-190249.
• 25. Enko D, Meinitzer A, Brandmayr W, Halwachs-Baumann G, Schnedl WJ, KriegshaÈuser G. Association between increased plasma levels of homocysteine and depression observed in individuals with primary lactose malabsorption. . PLoS ONE 2018;13(8). doi: 10.1371/journal.pone.0202567.
• 26. Brenda W.J.H. Penninx, Jack M. Guralnik, Luigi Ferrucci, Linda P. Fried, Robert H. Allen, Sally P. Stabler et al. Vitamin B12 Deficiency and Depression in Physically Disabled Older Women: Epidemiologic Evidence From the Women’s Health and Aging Study. Am J Psychiatry 2000; 157:715–721.
• 27. Obeid R, Schorr H, Eckert R, Herrmann W. Vitamin B12 status in the elderly as judged by available biochemical markers. Clin Chem 2004;50:238–41.
• 28. Ford AH, Flicker L, Thomas J, Norman P, Jamrozik K, Almeida OP. Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial. J Clin Psychiatry .2008;69(8):1203-9.
• 29. Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ 2004;171(8):897–904.
• 30. Erden S,Şakar Ş, Fatma Ş, Çakır H, Gelincik A, Kılıç L, et al. The Properties of Vitamin B12 Deficiency in the Patients of an Outpatient Clinic. Turkiye Klinikleri Journal of Medical Sciences 2010;30(6):1845.
• 31. Ni J, Zhang L, Zhou T, Xu WJ, Xue JL, Cao N et al.Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province. China J Chin Med Assoc. 2017;80(3): 147–153.
• 32. Kale A, Naphade N, Sapkale S, Kamaraju M, Pillai A, Joshi S et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res. 2010;175(1–2):47–53.